New implant offers hope for glaucoma patients failing drops

This early study tests a new device called the GORE Glaucoma Drainage Implant in 30 adults with primary open-angle glaucoma that eye drops cannot control or who are at high risk of scarring from standard surgery. The goal is to see if the implant safely lowers eye pressure by at least 20% at 6 months while using the same or fewer eye drops. This is not a cure, but aims to better manage the disease and reduce the need for daily medications.